Patents by Inventor Panqing He

Panqing He has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HYDROCARBON RECOVERY DISPERSIONS
    Publication number: 20150075798
    Abstract: Compositions and dispersions comprising hydrophobically modified polyacrylamide (HMPAM) or associative polymers and small particles useful in hydrocarbon recovery and enhanced oil recovery processes using the same. Non-limiting embodiments include those using metal oxide small particles, including fumed silica having primary particles in the nanoparticle size range.
    Type: Application
    Filed: September 16, 2014
    Publication date: March 19, 2015
    Inventors: Yongchun TANG, Hongxin TANG, Panqing HE
  • Treatment of microbial infections with compounds that inhibit 4-hydroxyphenylpyruvate dioxygenase
    Patent number: 8354451
    Abstract: Methods of inhibiting phagolysosomal fusion in patients infected with a microorganism involve the administration of a 4-hydroxyphenylpyruvate dioxygenase (HPPD)-inhibiting compound, such as 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC) to the patient. A HPPD-inhibiting compound administered in an amount effective to enhance phagolysosomal fusion in the macrophages or neutrophils of the patient reduces or treats the infection. Methods for treating bacterial infections by administering a HPPD-inhibiting compound and reducing the production of pyomelanin or melanin in microorganisms are disclosed.
    Type: Grant
    Filed: March 9, 2010
    Date of Patent: January 15, 2013
    Assignee: The UWM Research Foundation, Inc.
    Inventors: Graham R. Moran, Panqing He
  • TREATMENT OF MICROBIAL INFECTIONS WITH COMPOUNDS THAT INHIBIT 4-HYDROXYPHENYLPYRUVATE DIOXYGENASE
    Publication number: 20100227936
    Abstract: Methods of inhibiting phagolysosomal fusion in patients infected with a microorganism involve the administration of a 4-hydroxyphenylpyruvate dioxygenase (HPPD)-inhibiting compound, such as 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC) to the patient. A HPPD-inhibiting compound administered in an amount effective to enhance phagolysosomal fusion in the macrophages or neutrophils of the patient reduces or treats the infection. Methods for treating bacterial infections by administering a HPPD-inhibiting compound and reducing the production of pyomelanin or melanin in microorganisms are disclosed.
    Type: Application
    Filed: March 9, 2010
    Publication date: September 9, 2010
    Inventors: Graham R. Moran, Panqing He